Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (31-40 of 356) with videos related to

Pageof 36
Sort By:
Tuberculosis and Respiratory Diseases|March 19, 2020
Current Diagnosis and Management of Hypersensitivity PneumonitisPaolo Maria Leone, Luca Richeldi
Expert Opinion on Emerging Drugs|May 17, 2021
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trialsGiacomo Sgalla, Marialessia Lerede, Luca Richeldi
American Journal of Respiratory and Critical Care Medicine|June 23, 2011
Viruses and acute exacerbations of idiopathic pulmonary fibrosis: rest in peace?Martin R J Kolb, Luca Richeldi
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 7, 2006
Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?Fabrizio Luppi, Stefania Cerri, Luca Richeldi
American Journal of Respiratory and Critical Care Medicine|August 14, 2020
Reply to Fenton <i>et al.</i>: An Expanded COVID-19 Telemedicine Intermediate Care Model Using Repurposed Hotel RoomsTeresa Bruni, Ajit Lalvani, Luca Richeldi
Expert Opinion on Drug Safety|April 21, 2021
An updated safety review of the drug treatments for idiopathic pulmonary fibrosisGiacomo Sgalla, Alessia Comes, Luca Richeldi
Expert Review of Respiratory Medicine|August 24, 2011
Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY programLuca Richeldi, Roland M du Bois
American Journal of Respiratory and Critical Care Medicine|June 17, 2020
Telemedicine-enabled Accelerated Discharge of Patients Hospitalized with COVID-19 to Isolation in Repurposed Hotel RoomsTeresa Bruni, Ajit Lalvani, Luca Richeldi
American Journal of Respiratory and Critical Care Medicine|January 8, 2010
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed?Fabrizio Luppi, Bianca Beghé, Luca Richeldi
Respirology (Carlton, Vic.)|December 17, 2019
Twenty-five years of Respirology: Advances in idiopathic pulmonary fibrosisFrancesco Varone, Yoshikazu Inoue, Luca Richeldi
Pageof 36

Showing results (31-40 of 356) with videos related to

Sort By:
Pageof 36
Tuberculosis and Respiratory Diseases|March 19, 2020
Current Diagnosis and Management of Hypersensitivity PneumonitisPaolo Maria Leone, Luca Richeldi
Expert Opinion on Emerging Drugs|May 17, 2021
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trialsGiacomo Sgalla, Marialessia Lerede, Luca Richeldi
American Journal of Respiratory and Critical Care Medicine|June 23, 2011
Viruses and acute exacerbations of idiopathic pulmonary fibrosis: rest in peace?Martin R J Kolb, Luca Richeldi
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 7, 2006
Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?Fabrizio Luppi, Stefania Cerri, Luca Richeldi
American Journal of Respiratory and Critical Care Medicine|August 14, 2020
Reply to Fenton <i>et al.</i>: An Expanded COVID-19 Telemedicine Intermediate Care Model Using Repurposed Hotel RoomsTeresa Bruni, Ajit Lalvani, Luca Richeldi
Expert Opinion on Drug Safety|April 21, 2021
An updated safety review of the drug treatments for idiopathic pulmonary fibrosisGiacomo Sgalla, Alessia Comes, Luca Richeldi
Expert Review of Respiratory Medicine|August 24, 2011
Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY programLuca Richeldi, Roland M du Bois
American Journal of Respiratory and Critical Care Medicine|June 17, 2020
Telemedicine-enabled Accelerated Discharge of Patients Hospitalized with COVID-19 to Isolation in Repurposed Hotel RoomsTeresa Bruni, Ajit Lalvani, Luca Richeldi
American Journal of Respiratory and Critical Care Medicine|January 8, 2010
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed?Fabrizio Luppi, Bianca Beghé, Luca Richeldi
Respirology (Carlton, Vic.)|December 17, 2019
Twenty-five years of Respirology: Advances in idiopathic pulmonary fibrosisFrancesco Varone, Yoshikazu Inoue, Luca Richeldi
Pageof 36